Chelsea Therapeutics International CHTP
Last Post: 03/12/2014 7:20:48 PM
Board Marks: 0
Posts Today: 0
Board Views Today: 1
Chelsea Therapeutics International, Ltd. (NASDAQ: CHTP)
Chelsea Therapeutics is a biopharmaceutical development company that acquires and develops innovative products for the treatment of a variety of human diseases, including central nervous system disorders. Chelsea is currently pursuing FDA approval in the U.S. for Northera™ (droxidopa), a novel, late-stage, orally-active therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension in patients with primary autonomic failure.
Company Website: http://chelseatherapeutics.com/
Chelsea Therapeutics is a biopharmaceutical development company that acquires and develops innovative products for the treatment of a variety of human diseases, including central nervous system disorders. Chelsea is currently pursuing FDA approval in the U.S. for Northera™ (droxidopa), a novel, late-stage, orally-active therapeutic agent for the treatment of symptomatic neurogenic orthostatic hypotension in patients with primary autonomic failure.
Company Website: http://chelseatherapeutics.com/
Chelsea Therapeutics International (NASDAQ: CHTP) Stock Message Board
Post
Subject
Author
Posted On
| 3 | Latest Chelsea Therapeutics International (CHTP) | Stock_Tracker | 03/12/2014 7:20:48 PM |
| 2 | CHTP Stock Charts Last: -0.16 Wednesday, February | chartguy89 | 02/26/2014 11:28:32 PM |
| 1 | CHTP Stock Chart 4.79 Sunday, February 9, 2014 | chartguy89 | 02/09/2014 10:03:56 PM |